CMB International
招银国际
CMB International (招银国际, CMBI) shows up across elsewhere's corpus as an active investment institution spanning semiconductors, biotech, automotive and enterprise AI. It led Raysolve's nearly RMB 100 million Pre-A4 round for near-eye displays , led Yinjia Bio's nearly RMB 100 million Series A , and co-led KH Automotive's 300-million-yuan-plus Series C alongside SDIC Merchant ; it also joined rounds for synthetic-biology company Bota Bio , METiS Pharmaceuticals , Zhuiyi , Huaxin Biotech's B+ and Nankai Hecheng . Its most recent appearance is as a funder of Whale's July 2026 $40 million C3 round, where the money came through what 源码资本's piece describes as CMBI's "fund focused on AI and frontier technology" — a hint of how the institution has been organizing its newer tech exposure . elsewhere's corpus doesn't carry standalone coverage of CMBI itself — its founding background, structure and overall AUM — only these deal-level appearances.
AI-generated — may contain errors, please verify.
Coverage
Raysolve Raises Nearly 100 Million Yuan in Pre-A4 Funding to Accelerate Commercialization of Near-Eye Displays and Optical Interconnects
Focused on core Micro-LED technology, advancing the commercialization of near-eye displays and optical interconnects
Whale | Whale Raises $40 Million in Series C3 Round, Bringing Total Series C Funding Past $100 Million
An enterprise-grade, AI-native technology company serving global markets, managing more than 600,000 edge AI nodes for over 1,600 large enterprises worldwide.
Whale Raises $40 Million in C3 Round, Bringing Total Series C Funding to Over $100 Million | Linear Portfolio
Continued to attract long-term commitments from a diverse range of global institutional investors across multiple industries.
3D Cell Manufacturing Platform Huaxin Biotech Closes Series B+ Round to Accelerate Cell Therapy Commercialization for Global Clients
Ushering in the 2.0 era of cell-based industrialization.
Nankai Hecheng Completes 200 Million Yuan Series B Round | BlueRun Ventures Family
Accelerating Toward a Trillion-Yuan Future for the Polypeptide Industry
Year-end good news: CDH Investments has raised 5 billion yuan for logistics investments.
Insurance capital is turning its attention to real estate investments.
MaHui Member KH Automotive Technologies Co., Ltd. Raises Over 300 Million Yuan in Series C; Source Code Capital Co-Led Series B
Including this Series C round, KH Automotive Technologies Co., Ltd. has completed four funding rounds in total, raising nearly RMB 1 billion in aggregate.
Yinjia Biotech Closes Nearly RMB 100 Million Series A Round to Accelerate Buildout of Upstream Core Protein Ingredient Synthetic Biology Platform
Staying true to our mission as "protein craftsmen."
New Tracks, Interdisciplinary Fields, Down-Market Expansion, Data Infrastructure... Four Companies Raise Nearly 1.2 Billion RMB in Funding | FreeS Family Funding News · Vol 10
Looking forward to working alongside more outstanding founders.
Quantum Computing, 3D Sensor Chip Companies Secure New Funding; New Brands, Robotics, and Healthcare Firms Advance Globally | Rongbao · April
Summer begins, and all things grow.
Huashun Xin'an Closes Hundreds of Millions of RMB in Series C Funding to Build Cyberspace Security Ecosystem
Build a world-class cyberspace mapping engine, and construct the foundational infrastructure for cyberspace security ecosystems.
5Y News | METiS Pharmaceuticals Closes Two Consecutive Rounds Raising $150 Million Total
Become an industry innovation leader.
Code Engraved | METiS Pharmaceuticals Announces Two Consecutive Rounds totaling $150 Million
The most advanced pipeline programs are expected to begin pivotal clinical trials in 2023.
7 Companies Raised Nearly 1.5 Billion Yuan, 4 Valued Above 1 Billion Yuan | FreeS Family Funding News · September
Every step of growth for an innovative company: from 0 to 1, from 1 to 10, and from 10 to 100
As Fierce as August | 5Y News Monthly
The big news from last month.
5Y News | Synthetic Biology Company Bota Bio Raises Over $100 Million to Accelerate Efficient Design and Scaled Production of Bio-based Products
5Y Capital continues to pay close attention to emerging technologies at the intersection of information science and life sciences.
Synthetic biology company Bota Bio (Enhe Biotechnology) announced the completion of a Series B funding round exceeding $100 million, with existing shareholder Source Code Capital continuing to increase its stake.
Accelerating the design and production of high-performance, sustainable products through synthetic biology.
5Y News | Zhuiyi Technology Secures Strategic Investment of Several Hundred Million RMB
Exploring the commercial boundaries of AI technology.
